RAPT Therapeutics Inc (RAPT)
4.03
-0.11
(-2.66%)
USD |
NASDAQ |
May 17, 16:00
4.03
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Cash from Operations (Quarterly): -27.08M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -27.08M |
| December 31, 2023 | -27.75M |
| September 30, 2023 | -21.88M |
| June 30, 2023 | -28.81M |
| March 31, 2023 | -18.60M |
| December 31, 2022 | -22.85M |
| September 30, 2022 | -17.15M |
| June 30, 2022 | -15.20M |
| March 31, 2022 | -15.58M |
| December 31, 2021 | -20.68M |
| September 30, 2021 | -12.52M |
| June 30, 2021 | -13.92M |
| March 31, 2021 | -13.91M |
| Date | Value |
|---|---|
| December 31, 2020 | -15.37M |
| September 30, 2020 | -9.953M |
| June 30, 2020 | -6.427M |
| March 31, 2020 | -8.745M |
| December 31, 2019 | -5.688M |
| September 30, 2019 | -12.14M |
| June 30, 2019 | -9.013M |
| March 31, 2019 | -8.634M |
| December 31, 2018 | -9.211M |
| September 30, 2018 | -8.863M |
| June 30, 2018 | -7.262M |
| March 31, 2018 | -7.617M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-28.81M
Minimum
Jun 2023
-5.688M
Maximum
Dec 2019
-16.16M
Average
-15.28M
Median
Cash from Operations (Quarterly) Benchmarks
| Emergent BioSolutions Inc | -62.60M |
| Avinger Inc | -3.389M |
| Tonix Pharmaceuticals Holding Corp | -17.58M |
| Skye Bioscience Inc | -4.708M |
| Axsome Therapeutics Inc | -53.47M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 15.89M |
| Cash from Financing (Quarterly) | 9.036M |
| Free Cash Flow | -106.00M |
| Free Cash Flow Per Share (Quarterly) | -0.7039 |
| Free Cash Flow Yield | -68.28% |